Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 22
Filter
Add more filters










Publication year range
1.
Bioanalysis ; 7(15): 1885-99, 2015.
Article in English | MEDLINE | ID: mdl-26295989

ABSTRACT

Protein denaturation is the common basis for enzyme inactivation and inactivation of pathogens, necessary for preservation and safe handling of biosamples for downstream analysis. While heat-stabilization technology has been used in proteomic and peptidomic research since its introduction in 2009, the advantages of using the technique for simultaneous pathogen inactivation have only recently been addressed. The time required for enzyme inactivation by heat (≈1 min) is short compared with chemical treatments, and inactivation is irreversible in contrast to freezing. Heat stabilization thus facilitates mass spectrometric studies of biomolecules with a fast conversion rate, and expands the chemical space of potential biomarkers to include more short-lived entities, such as phosphorylated proteins, in tissue samples as well as whole-blood (dried blood sample) samples.


Subject(s)
Mass Spectrometry/methods , Proteomics/methods , Protein Denaturation , Tissue Fixation
2.
J Neurochem ; 130(2): 199-214, 2014 Jul.
Article in English | MEDLINE | ID: mdl-24749662

ABSTRACT

Neuropeptide transmitters involved in nociceptive processes are more likely to be expressed in the dorsal than the ventral horn of the spinal cord. This study was designed to examine the relative distribution of neuropeptides between the dorsal and ventral spinal cord in naïve mice using liquid chromatography, high-resolution mass spectrometry. We identified and relatively quantified 36 well-characterized full-length neuropeptides and an additional 168 not previously characterized peptides. By extraction with organic solvents we identified seven additional full-length neuropeptides. The peptide [des-Ser1]-cerebellin (desCER), originating from cerebellin precursor protein 1 (CBLN1), was predominantly expressed in the dorsal horn. Immunohistochemistry showed the presence of CBLN1 immunoreactivity with a punctate cytoplasmic pattern in neuronal cell bodies throughout the spinal gray matter. The signal was stronger in the dorsal compared to the ventral horn, with most CBLN1 positive cells present in outer laminae II/III, colocalizing with calbindin, a marker for excitatory interneurons. Intrathecal injection of desCER induced a dose-dependent mechanical hypersensitivity but not heat or cold hypersensitivity. This study provides evidence for involvement of desCER in nociception and provides a platform for continued exploration of involvement of novel neuropeptides in the regulation of nociceptive transmission. Neuropeptides involved in nociceptive processes are more likely to be expressed in the dorsal than the ventral horn of spinal cord. Well-characterized full-length neuropeptides as well as uncharacterized neuropeptides were quantified by mass spectrometry. The CBLN1-derived peptide [des-Ser1]-cerebellin (desCER) is predominantly expressed in the dorsal horn, and intrathecal injection of desCER induced a dose-dependent mechanical hypersensitivity.


Subject(s)
Nerve Tissue Proteins/pharmacology , Nerve Tissue Proteins/physiology , Neuropeptides/analysis , Nociception/physiology , Spinal Cord/chemistry , Algorithms , Animals , Chromatography, High Pressure Liquid , Cluster Analysis , Cold Temperature , Cyclotrons , Fourier Analysis , Hot Temperature , Hyperalgesia/prevention & control , Immunohistochemistry , Injections, Spinal , Male , Mass Spectrometry , Mice , Mice, Inbred C57BL , Nerve Tissue Proteins/analysis , Neuropeptides/physiology , Physical Stimulation , Signal Transduction/physiology
3.
Mol Cell Proteomics ; 12(6): 1489-501, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23382104

ABSTRACT

The separation between biological and technical variation without extensive use of technical replicates is often challenging, particularly in the context of different forms of protein and peptide modifications. Biosampling procedures in the research laboratory are easier to conduct within a shorter time frame and under controlled conditions as compared with clinical sampling, with the latter often having issues of reproducibility. But is the research laboratory biosampling really less variable? Biosampling introduces within minutes rapid tissue-specific changes in the cellular microenvironment, thus inducing a range of different pathways associated with cell survival. Biosampling involves hypoxia and, depending on the circumstances, hypothermia, circumstances for which there are evolutionarily conserved defense strategies in the range of species and also are relevant for the range of biomedical conditions. It remains unclear to what extent such adaptive processes are reflected in different biosampling procedures or how important they are for the definition of sample quality. Lately, an increasing number of comparative studies on different biosampling approaches, post-mortem effects and pre-sampling biological state, have investigated such immediate early biosampling effects. Commonalities between biosampling effects and a range of ischemia/reperfusion- and hypometabolism/anoxia-associated biological phenomena indicate that even small variations in post-sampling time intervals are likely to introduce a set of nonrandom and tissue-specific effects of experimental importance (both in vivo and in vitro). This review integrates the information provided by these comparative studies and discusses how an adaptive biological perspective in biosampling procedures may be relevant for sample quality issues.


Subject(s)
Proteins/analysis , Specimen Handling/standards , Adaptation, Physiological , Animals , Cellular Microenvironment/physiology , Gene Expression Regulation , Humans , Hypothermia/genetics , Hypothermia/metabolism , Hypoxia/genetics , Hypoxia/metabolism , Observer Variation , Organ Specificity , Proteins/genetics , Proteins/metabolism , Proteomics , Reproducibility of Results , Species Specificity , Time Factors
4.
Bioanalysis ; 5(1): 31-9, 2013 Jan.
Article in English | MEDLINE | ID: mdl-23256470

ABSTRACT

BACKGROUND: Sample stability is critical for accurate analysis of drug compounds in biosamples. The use of additives to eradicate the enzymatic activity causing loss of these analytes has its limitations. RESULTS: A novel technique for sample stabilization by rapid, high-temperature heating was used. The stability of six commercial drugs in blood and blood spots was investigated under various conditions with or without heat stabilization at 95°C. Oseltamivir, cefotaxime and ribavirin were successfully stabilized by heating whereas significant losses were seen in unheated samples. Amodiaquine was stable with and without heating. Artemether and dihydroartemisinin were found to be very heat sensitive and began to decompose even at 60°C. CONCLUSION: Heat stabilization is a viable technique to maintain analytes in blood spot samples, without the use of chemical additives, by stopping the enzymatic activity that causes sample degradation.


Subject(s)
Analytic Sample Preparation Methods/methods , Dried Blood Spot Testing/methods , Hot Temperature , Pharmaceutical Preparations/blood , Pharmaceutical Preparations/metabolism , Amodiaquine/blood , Amodiaquine/metabolism , Artemether , Artemisinins/blood , Artemisinins/metabolism , Butyrylcholinesterase/metabolism , Cefotaxime/blood , Cefotaxime/metabolism , Drug Stability , Humans , Oseltamivir/blood , Oseltamivir/metabolism
5.
Neuropharmacology ; 62(1): 347-57, 2012 Jan.
Article in English | MEDLINE | ID: mdl-21856315

ABSTRACT

Excessive activation of the hypothalamic-pituitary-adrenal (HPA) axis has been associated with numerous diseases, including depression, and the tricyclic antidepressant imipramine has been shown to suppress activity of the HPA axis. Central hypothalamic control of the HPA axis is complex and involves a number of neuropeptides released from multiple hypothalamic subnuclei. The present study was therefore designed to determine the effects of imipramine administration on the mouse hypothalamus using a peptidomics approach. Among the factors found to be downregulated after acute (one day) or chronic (21 days) imipramine administration were peptides derived from secretogranin 1 (chromogranin B) as well as peptides derived from cerebellin precursors. In contrast, peptides SRIF-14 and SRIF-28 (1-11) derived from somatostatin (SRIF, somatotropin release inhibiting factor) were significantly upregulated by imipramine in the hypothalamus. Because diminished SRIF levels have long been known to occur in depression, a second part of the study investigated the roles of individual SRIF receptors in mediating potential antidepressant effects. SRA880, an antagonist of the somatostatin-1 autoreceptor (sst1) which positively modulates release of endogenous SRIF, was found to synergize with imipramine in causing antidepressant-like effects in the tail suspension test. Furthermore, chronic co-administration of SRA880 and imipramine synergistically increased BDNF mRNA expression in the cerebral cortex. Application of SRIF or L054264, an sst2 receptor agonist, but not L803807, an sst4 receptor agonist, increased phosphorylation of CaMKII and GluR1 in cerebrocortical slices. Our present experiments thus provide evidence for antidepressant-induced upregulation of SRIF in the brain, and strengthen the notion that augmented SRIF expression and signaling may counter depressive-like symptoms. This article is part of a Special Issue entitled 'Anxiety and Depression'.


Subject(s)
Antidepressive Agents, Tricyclic/pharmacology , Gene Expression Regulation/drug effects , Hypothalamus/drug effects , Imipramine/pharmacology , Neuropeptides/metabolism , Analysis of Variance , Animals , Cerebral Cortex/drug effects , Cerebral Cortex/metabolism , Chromogranin B/metabolism , Hindlimb Suspension/methods , Male , Mass Spectrometry , Mice , Mice, Inbred C57BL , Nerve Tissue Proteins , Phosphorylation/drug effects , Piperazines/pharmacology , Protein Precursors/metabolism , Quinolines/pharmacology , Somatostatin/metabolism , Somatostatin-28/metabolism , Time Factors
6.
J Proteomics ; 75(1): 145-59, 2011 Dec 10.
Article in English | MEDLINE | ID: mdl-21708298

ABSTRACT

This review focuses on post sampling changes and how the Stabilizor system has been used to control this natural biological process and potential implications on cancer-specific biomarkers due to post sampling changes. Tissue sampling is a major traumatic event that can have drastic effects within a very short timeframe at the molecular level [1] resulting in loss of sample quality due to post-mortem changes. A heat-stabilization technology, using the Stabilizor system, has been developed to quickly and permanently abolish the enzymatic activity that causes these changes post-sampling and so preserve sample quality. The Stabilizor system has been shown to give better sample quality when analyzing a variety of tissues in various proteomic workflows. In this paper we discuss the impact of using heat-stabilized tissue in different proteomic applications. Based on our observations regarding the overlap between commonly changing proteins and proteins found to change post-mortem we also highlight a group of proteins of particular interest in cancer studies.


Subject(s)
Biomarkers/analysis , Disease , Hot Temperature , Postmortem Changes , Proteins/analysis , Proteomics/methods , Animals , Biomarkers/chemistry , Biomarkers/metabolism , Disease/classification , Humans , Protein Stability , Proteins/chemistry , Proteins/metabolism
7.
Mol Cell Proteomics ; 10(3): M900229MCP200, 2011 Mar.
Article in English | MEDLINE | ID: mdl-20110281

ABSTRACT

Little is known about the nature of post mortem degradation of proteins and peptides on a global level, the so-called degradome. This is especially true for nonneural tissues. Degradome properties in relation to sampling procedures on different tissues are of great importance for the studies of, for instance, post translational modifications and/or the establishment of clinical biobanks. Here, snap freezing of fresh (<2 min post mortem time) mouse liver and pancreas tissue is compared with rapid heat stabilization with regard to effects on the proteome (using two-dimensional differential in-gel electrophoresis) and peptidome (using label free liquid chromatography). We report several proteins and peptides that exhibit heightened degradation sensitivity, for instance superoxide dismutase in liver, and peptidyl-prolyl cis-trans isomerase and insulin C-peptides in pancreas. Tissue sampling based on snap freezing produces a greater amount of degradation products and lower levels of endogenous peptides than rapid heat stabilization. We also demonstrate that solely snap freezing related degradation can be attenuated by subsequent heat stabilization. We conclude that tissue sampling involving a rapid heat stabilization step is preferable to freezing with regard to proteomic and peptidomic sample quality.


Subject(s)
Liver/metabolism , Pancreas/metabolism , Peptides/metabolism , Postmortem Changes , Proteome/metabolism , Proteomics/methods , Temperature , Amino Acid Sequence , Animals , Databases, Protein , Electrophoresis, Gel, Two-Dimensional , Insulin/chemistry , Insulin/metabolism , Mice , Mice, Inbred C57BL , Molecular Sequence Data , Peptide Library , Peptides/chemistry , Protein Isoforms/chemistry , Protein Isoforms/metabolism , Proteome/chemistry
8.
BMC Dev Biol ; 10: 30, 2010 Mar 18.
Article in English | MEDLINE | ID: mdl-20298575

ABSTRACT

BACKGROUND: Endogenous peptides such as neuropeptides are involved in numerous biological processes in the fully developed brain but very little is known about their role in brain development. Japanese quail is a commonly used bird model for studying sexual dimorphic brain development, especially adult male copulatory behavior in relation to manipulations of the embryonic endocrine system. This study uses a label-free liquid chromatography mass spectrometry approach to analyze the influence of age (embryonic days 12 vs 17), sex and embryonic day 3 ethinylestradiol exposure on the expression of multiple endogenous peptides in the developing diencephalon. RESULTS: We identified a total of 65 peptides whereof 38 were sufficiently present in all groups for statistical analysis. Age was the most defining variable in the data and sex had the least impact. Most identified peptides were more highly expressed in embryonic day 17. The top candidates for EE2 exposure and sex effects were neuropeptide K (downregulated by EE2 in males and females), gastrin-releasing peptide (more highly expressed in control and EE2 exposed males) and gonadotropin-inhibiting hormone related protein 2 (more highly expressed in control males and displaying interaction effects between age and sex). We also report a new potential secretogranin-2 derived neuropeptide and previously unknown phosphorylations in the C-terminal flanking protachykinin 1 neuropeptide. CONCLUSIONS: This study is the first larger study on endogenous peptides in the developing brain and implies a previously unknown role for a number of neuropeptides in middle to late avian embryogenesis. It demonstrates the power of label-free liquid chromatography mass spectrometry to analyze the expression of multiple endogenous peptides and the potential to detect new putative peptide candidates in a developmental model.


Subject(s)
Coturnix/embryology , Diencephalon/chemistry , Diencephalon/embryology , Gene Expression Regulation, Developmental , Neuropeptides/analysis , Animals , Chromatography, Liquid , Coturnix/genetics , Coturnix/metabolism , Diencephalon/metabolism , Embryo, Nonmammalian/metabolism , Embryonic Development , Female , Male , Mass Spectrometry , Neuropeptides/genetics , Sex Characteristics
9.
Mol Cell Proteomics ; 8(5): 1094-104, 2009 May.
Article in English | MEDLINE | ID: mdl-19131325

ABSTRACT

The principal causative pathology of Parkinson disease is the progressive degeneration of dopaminergic neurons in the substantia nigra pars compacta projecting to the striatum in the brain. The information regarding the expression of neuropeptides in parkinsonism is very limited. Here we have elucidated striatal neuropeptide mechanisms in experimental parkinsonism using the unilateral 6-hydroxydopamine model to degenerate dopamine neurons. A thoroughly controlled sample preparation technique together with a peptidomics approach and targeted neuropeptide sequence collections enabled sensitive detection, identification, and relative quantitation of a great number of endogenous neuropeptides. Previously not recognized alterations in neuropeptide levels were identified in the unilateral lesioned mice with or without subchronic 3,4-dihydroxy-L-phenylalanine administration, the conventional treatment of Parkinson disease. Several of these peptides originated from the same precursor such as secretogranin-1, somatostatin, prodynorphin, and cholecystokinin. Disease-related biotransformation of precursors into individual peptides was observed in the experimental model of Parkinson disease. Several previously unreported potentially biologically active peptides were also identified from the striatal samples. This study provides further evidence that neuropeptides take part in mediating the central nervous system failure associated with Parkinson disease.


Subject(s)
Neostriatum/metabolism , Neostriatum/pathology , Parkinson Disease/metabolism , Parkinson Disease/pathology , Peptides/metabolism , Amino Acid Sequence , Animals , Cholecystokinin/chemistry , Cholecystokinin/metabolism , Chromogranin B/chemistry , Chromogranin B/metabolism , Disease Models, Animal , Enkephalins/chemistry , Enkephalins/metabolism , Mice , Molecular Sequence Data , Oxidopamine , Parkinson Disease/enzymology , Peptides/chemistry , Postmortem Changes , Protein Precursors/chemistry , Protein Precursors/metabolism , Reproducibility of Results , Somatostatin/chemistry , Somatostatin/metabolism , Tissue Extracts , Tyrosine 3-Monooxygenase/metabolism
10.
J Proteome Res ; 8(2): 974-81, 2009 Feb.
Article in English | MEDLINE | ID: mdl-19159280

ABSTRACT

After tissue or body fluid sampling, proteases and other protein-modifying enzymes can rapidly change composition of the proteome. As a direct consequence, analytical results will reflect a mix of in vivo proteome and ex vivo degradation products. Vital information about the presampling state may be destroyed or distorted, leading to variation between samples and incorrect conclusions. Sample stabilization and standardization of sample handling can reduce or eliminate this problem. Here, a novel tissue stabilization system which utilizes a combination of heat and pressure under vacuum was used to stop degradation in mouse brain tissue immediately after sampling. It was found by biochemical assays that enzymatic activity was reduced to background levels in stabilized samples. Western blot analysis confirmed that post-translational phosphorylations of analyzed proteins were stable and conserved for up to 2 h at room temperature and that peptide extracts were devoid of abundant protein degradation fragments. The combination of reduced complexity and proteolytic inactivation enabled mass spectrometric identification of several neuropeptides and endogenous peptides including modified species at higher levels compared to nonstabilized samples. The tissue stabilizing system ensures reproducible and rapid inactivation of enzymes. Therefore, the system provides a powerful improvement to proteomics by greatly reducing the complexity and dynamic range of the proteome in tissue samples and enables enhanced possibilities for discovery and analysis of clinically relevant protein/peptide biomarkers.


Subject(s)
Hot Temperature , Protein Stability , Proteins/chemistry , Proteome/analysis , Proteomics , Tissue Array Analysis , Animals , Brain Chemistry , Mice , Peptides/analysis , Protein Processing, Post-Translational , Proteins/metabolism , Proteomics/instrumentation , Proteomics/methods , Spectrometry, Mass, Electrospray Ionization , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Tissue Array Analysis/instrumentation , Tissue Array Analysis/methods , Vacuum
11.
J Proteome Res ; 7(7): 3049-53, 2008 Jul.
Article in English | MEDLINE | ID: mdl-18549260

ABSTRACT

The SwePep database is designed for endogenous peptides and mass spectrometry. It contains information about the peptides such as mass, pl, precursor protein and potential post-translational modifications. Here, we have improved and extended the SwePep database with tandem mass spectra, by adding a locally curated version of the global proteome machine database (GPMDB). In peptidomic experiment practice, many peptide sequences contain multiple tandem mass spectra with different quality. The new tandem mass spectra database in SwePep enables validation of low quality spectra using high quality tandem mass spectra. The validation is performed by comparing the fragmentation patterns of the two spectra using algorithms for calculating the correlation coefficient between the spectra. The present study is the first step in developing a tandem spectrum database for endogenous peptides that can be used for spectrum-to-spectrum identifications instead of peptide identifications using traditional protein sequence database searches.


Subject(s)
Databases, Factual , Peptides/analysis , Algorithms , Animals , Brain Chemistry , Chromatography, Liquid , Mice , Neuropeptides/analysis , Peptide Fragments/analysis , Protein Precursors/analysis , Proteome/analysis , Spectrometry, Mass, Electrospray Ionization , Tandem Mass Spectrometry
12.
PLoS One ; 3(2): e1589, 2008 Feb 13.
Article in English | MEDLINE | ID: mdl-18270577

ABSTRACT

L-3,4-dihydroxypheylalanine (L-dopa)-induced dyskinesia represent a debilitating complication of therapy for Parkinson's disease (PD) that result from a progressive sensitization through repeated L-dopa exposures. The MPTP macaque model was used to study the proteome in dopamine-depleted striatum with and without subsequent acute and chronic L-dopa treatment using two-dimensional difference in-gel electrophoresis (2D-DIGE) and mass spectrometry. The present data suggest that the dopamine-depleted striatum is so sensitive to de novo L-dopa treatment that the first ever administration alone would be able (i) to induce rapid post-translational modification-based proteomic changes that are specific to this first exposure and (ii), possibly, lead to irreversible protein level changes that would be not further modified by chronic L-dopa treatment. The apparent equivalence between first and chronic L-dopa administration suggests that priming would be the direct consequence of dopamine loss, the first L-dopa administrations only exacerbating the sensitization process but not inducing it.


Subject(s)
Dyskinesia, Drug-Induced/metabolism , Levodopa/adverse effects , Parkinson Disease/complications , Proteomics/methods , Animals , Corpus Striatum/chemistry , Disease Models, Animal , Electrophoresis, Gel, Two-Dimensional , Levodopa/administration & dosage , Macaca , Mass Spectrometry , Parkinson Disease/drug therapy , Protein Processing, Post-Translational , Rats
13.
Proteomics ; 7(24): 4445-56, 2007 Dec.
Article in English | MEDLINE | ID: mdl-18072205

ABSTRACT

Comparisons of transcriptional and translational expression in normal and abnormal states are important to reach an understanding of pathogenesis and pathophysiology. Maintaining the biochemical, molecular, and structural sample integrity is essential for correct sample comparisons. We demonstrate that both proteins and neuropeptides, including their PTMs, are subjected to massive degradation in the brain already 1 min postmortem. Further, markers for determining the integrity and status of a biological sample were identified. The protein fragment stathmin 2-20 correlated well with the general level of postmortem degradation and may serve as a sample quality indicator for future work, both in animal and human postmortem brains. Finally, a novel method for preventing degradation of proteins and peptides in postmortem tissue is presented using rapid and uniform conductive heat transfer on tissue prior to the actual sample preparation procedures, which enables the relatively low-abundant neuropeptides to remain intact, minimizes degradation of proteins by proteolysis, and conserves the PTMs of the neuropeptides.


Subject(s)
Brain Chemistry , Peptide Fragments/analysis , Peptides/analysis , Proteomics/methods , Stathmin/analysis , Animals , Biomarkers , Electrophoresis, Gel, Two-Dimensional , Female , Frozen Sections , Humans , Male , Microwaves , Mitogen-Activated Protein Kinases/metabolism , Neuropeptides/analysis , Phosphorylation , Postmortem Changes , Time Factors , Tissue Fixation
14.
J Proteome Res ; 6(10): 3952-61, 2007 Oct.
Article in English | MEDLINE | ID: mdl-17877381

ABSTRACT

FKBP-12, a 12 kDa FK506-binding protein (neuroimmunophilin), acts as a receptor for the immunosuppressant drug FK506. Neuroimmunophilins, including FKBP-12, are abundant in the brain and have been shown to be involved in reversing neuronal degeneration and preventing cell death. In this report, we have utilized several analytical techniques, such as in situ hybridization, Western blotting, two-dimensional gel electrophoresis, and liquid chromatography electrospray tandem mass spectrometry to study the transcriptional expression as well as protein levels of FKBP-12 in the unilateral 6-hydroxydopamine (6-OHDA) rat model of Parkinson's disease. The FKBP-12 protein was also detected directly on brain tissue sections using mass spectrometry profiling. We found increased levels of FKBP-12 mRNA and protein in the dorsal and middle part of the 6-OHDA lesioned striatum. Thus, these studies clearly demonstrate that FKBP-12 is increased in the brain of a common animal model of Parkinson's disease (PD). Additionally, we have identified potential binding partners to FKBP-12 that may be implicated in the pathophysiology of Parkinson's disease, such as alpha-enolase, 14-3-3 zeta/delta, pyruvate kinase isozymes, and heat shock protein 70, using surface plasmon resonance sensor technology in combination with mass spectrometry. In conclusion, these data strongly suggests that FKBP-12 is altered in an experimental model of PD.


Subject(s)
Corpus Striatum/metabolism , Parkinsonian Disorders/metabolism , RNA, Messenger/metabolism , Tacrolimus Binding Protein 1A/metabolism , Amino Acid Sequence , Animals , Chromatography, Liquid , Electrophoresis, Gel, Two-Dimensional , Glutathione Transferase/genetics , In Situ Hybridization , Male , Mice , Molecular Sequence Data , Oxidopamine , Parkinsonian Disorders/etiology , Protein Binding , Protein Interaction Mapping , Rats , Rats, Sprague-Dawley , Recombinant Fusion Proteins/chemistry , Recombinant Fusion Proteins/genetics , Spectrometry, Mass, Electrospray Ionization , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization , Surface Plasmon Resonance , Tacrolimus Binding Protein 1A/chemistry , Tacrolimus Binding Protein 1A/genetics
15.
J Proteome Res ; 6(7): 2888-95, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17559249

ABSTRACT

Differential quantification of proteins and peptides by LC-MS is a promising method to acquire knowledge about biological processes, and for finding drug targets and biomarkers. However, differential protein analysis using LC-MS has been held back by the lack of suitable software tools. Large amounts of experimental data are easily generated in protein and peptide profiling experiments, but data analysis is time-consuming and labor-intensive. Here, we present a fully automated method for scanning LC-MS/MS data for biologically significant peptides and proteins, including support for interactive confirmation and further profiling. By studying peptide mixtures of known composition, we demonstrate that peptides present in different amounts in different groups of samples can be automatically screened for using statistical tests. A linear response can be obtained over almost 3 orders of magnitude, facilitating further profiling of peptides and proteins of interest. Furthermore, we apply the method to study the changes of endogenous peptide levels in mouse brain striatum after administration of reserpine, a classical model drug for inducing Parkinson disease symptoms.


Subject(s)
Chromatography, Liquid , Mass Spectrometry , Peptides/analysis , Proteins/analysis , Software , Amino Acid Sequence , Animals , Corpus Striatum/chemistry , Mice , Molecular Sequence Data , Parkinson Disease/metabolism
16.
Mol Cell Proteomics ; 6(7): 1188-97, 2007 Jul.
Article in English | MEDLINE | ID: mdl-17401030

ABSTRACT

A new approach using targeted sequence collections has been developed for identifying endogenous peptides. This approach enables a fast, specific, and sensitive identification of endogenous peptides. Three different sequence collections were constituted in this study to mimic the peptidomic samples: SwePep precursors, SwePep peptides, and SwePep predicted. The searches for neuropeptides performed against these three sequence collections were compared with searches performed against the entire mouse proteome, which is commonly used to identify neuropeptides. These four sequence collections were searched with both Mascot and X! Tandem. Evaluation of the sequence collections was achieved using a set of manually identified and previously verified peptides. By using the three new sequence collections, which more accurately mimic the sample, 3 times as many peptides were significantly identified, with a false-positive rate below 1%, in comparison with the mouse proteome. The new sequence collections were also used to identify previously uncharacterized peptides from brain tissue; 27 previously uncharacterized peptides and potentially bioactive neuropeptides were identified. These novel peptides are cleaved from the peptide precursors at sites that are characteristic for prohormone convertases, and some of them have post-translational modifications that are characteristic for neuropeptides. The targeted protein sequence collections for different species are publicly available for download from SwePep.


Subject(s)
Databases, Protein , Neuropeptides/analysis , Proteome/analysis , Amino Acid Sequence , Animals , Humans , Mice , Proprotein Convertases/analysis , Protein Processing, Post-Translational
17.
Anal Chem ; 79(1): 15-6, 18-21, 2007 Jan 01.
Article in English | MEDLINE | ID: mdl-17262921

ABSTRACT

By comparing the proteins and peptides in diseased an normal tissues, researchers can identify differential expression patterns that may lead to biomarkers.


Subject(s)
Brain Chemistry/physiology , Disease Attributes , Mass Spectrometry/methods , Neuropeptides/analysis , Proteomics/methods , Animals , Biomarkers/analysis , Humans , Neuropeptides/metabolism
18.
BMC Bioinformatics ; 7: 475, 2006 Oct 26.
Article in English | MEDLINE | ID: mdl-17067368

ABSTRACT

BACKGROUND: Two-Dimensional Difference In Gel Electrophoresis (2D-DIGE) is a powerful tool for measuring differences in protein expression between samples or conditions. However, to remove systematic variability within and between gels the data has to be normalized. In this study we examined the ability of four existing and four novel normalization methods to remove systematic bias in data produced with 2D-DIGE. We also propose a modification of an existing method where the statistical framework determines whether a set of proteins shows an association with the predefined phenotypes of interest. This method was applied to our data generated from a monkey model (Macaca fascicularis) of Parkinson's disease. RESULTS: Using 2D-DIGE we analysed the protein content of the striatum from 6 control and 21 MPTP-treated monkeys, with or without de novo or long-term L-DOPA administration. There was an intensity and spatial bias in the data of all the gels examined in this study. Only two of the eight normalization methods evaluated ('2D loess+scale' and 'SC-2D+quantile') successfully removed both the intensity and spatial bias. In 'SC-2D+quantile' we extended the commonly used loess normalization method against dye bias in two-channel microarray systems to suit systems with three or more channels.Further, by using the proposed method, Differential Expression in Predefined Proteins Sets (DEPPS), several sets of proteins associated with the priming effects of L-DOPA in the striatum in parkinsonian animals were identified. Three of these sets are proteins involved in energy metabolism and one set involved proteins which are part of the microtubule cytoskeleton. CONCLUSION: Comparison of the different methods leads to a series of methodological recommendations for the normalization and the analysis of data, depending on the experimental design. Due to the nature of 2D-DIGE data we recommend that the p-values obtained in significance tests should be used as rankings only. Individual proteins may be interesting as such, but by studying sets of proteins the interpretation of the results are probably more accurate and biologically informative.


Subject(s)
Corpus Striatum/metabolism , Electrophoresis, Gel, Two-Dimensional/methods , Gene Expression Profiling/methods , Nerve Tissue Proteins/metabolism , Parkinson Disease, Secondary/metabolism , Proteome/metabolism , Animals , Corpus Striatum/drug effects , Disease Models, Animal , Levodopa , Macaca fascicularis , Movement Disorders/etiology , Movement Disorders/metabolism , Parkinson Disease, Secondary/chemically induced
19.
Mol Cell Proteomics ; 5(6): 998-1005, 2006 Jun.
Article in English | MEDLINE | ID: mdl-16501280

ABSTRACT

A new database, SwePep, specifically designed for endogenous peptides, has been constructed to significantly speed up the identification process from complex tissue samples utilizing mass spectrometry. In the identification process the experimental peptide masses are compared with the peptide masses stored in the database both with and without possible post-translational modifications. This intermediate identification step is fast and singles out peptides that are potential endogenous peptides and can later be confirmed with tandem mass spectrometry data. Successful applications of this methodology are presented. The SwePep database is a relational database developed using MySql and Java. The database contains 4180 annotated endogenous peptides from different tissues originating from 394 different species as well as 50 novel peptides from brain tissue identified in our laboratory. Information about the peptides, including mass, isoelectric point, sequence, and precursor protein, is also stored in the database. This new approach holds great potential for removing the bottleneck that occurs during the identification process in the field of peptidomics. The SwePep database is available to the public.


Subject(s)
Databases, Protein , Peptides/chemistry , Peptides/classification , Spectrometry, Mass, Electrospray Ionization , Animals , Hormones/chemistry , Hypothalamus/chemistry , Internet , Mice , Mice, Inbred C57BL , Nerve Tissue Proteins/chemistry , Neuropeptides/chemistry , Protein Processing, Post-Translational , Rats , Rats, Sprague-Dawley
20.
J Proteome Res ; 5(2): 262-9, 2006 Feb.
Article in English | MEDLINE | ID: mdl-16457591

ABSTRACT

PEP-19 is a neuronal calmodulin-binding protein, and as such, a putative modulator of calcium regulated processes. In the present study, we used proteomics technology approaches such as peptidomics and imaging MALDI mass spectrometry, as well as traditional techniques (immunoblotting and in situ hybridization) to identify PEP-19 and, specifically, to measure PEP-19 mRNA and protein levels in an animal model of Parkinson's disease. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) administration in mice resulted in a significant decrease in striatal PEP-19 mRNA. Capillary nano-flow liquid chromatography electrospray mass spectrometry analysis of striatal tissue revealed a significant decrease of the PEP-19 protein level. Moreover, imaging MALDI mass spectrometry also showed that PEP-19 protein was predominantly localized to the striatum of the brain tissue cross sections. After MPTP administration, PEP-19 levels were significantly reduced by 30%. We conclude that PEP-19 mRNA and protein expression are decreased in the striatum of a common animal model of Parkinson's disease. Further studies are needed to show the specific involvement of PEP-19 in the neurodegeneration seen in MPTP lesioned animals. Finally, this study has shown that the combination of traditional molecular biology techniques with novel, highly specific and sensitive mass spectrometry methods is advantageous in characterizing molecular events of many diseases, including Parkinson's disease.


Subject(s)
Corpus Striatum/metabolism , Nerve Tissue Proteins/metabolism , Parkinsonian Disorders/metabolism , Peptides/metabolism , RNA, Messenger/metabolism , Animals , Corpus Striatum/pathology , In Situ Hybridization , MPTP Poisoning/complications , Male , Mice , Mice, Inbred C57BL , Nerve Degeneration/pathology , Parkinsonian Disorders/chemically induced , Parkinsonian Disorders/pathology , Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization
SELECTION OF CITATIONS
SEARCH DETAIL
...